NDA 020478 · Abbvie
Ultane
Sevoflurane · Inhalation · General Anesthetic
NovelLast checked: Nov 19, 2026Latest source record: Feb 3, 2025 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1995
Jun 7, 1995
Approved uses
2
Original approval plus efficacy supplements
Registered trials
832
71 Phase 3, 53 recruiting
FAERS reports
8,423
7,983 serious, 569 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Feb 12, 2025.
INDICATIONS AND USAGE ULTANE is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery. ULTANE should be administered only by persons trained in the administration of general anesthesia. Facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment, and circulatory resuscitation must be immediately available. Since level of anesthesia may be altered rapidly, only vaporizers producing predictable concentrations of sevoflurane should be used.
Therapeutic areas: Pain and anesthesia
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Mar 30, 2001 Supplement 6 · Efficacy LabelReviewLetter
- Jun 7, 1995 Original approval · Type 1 - New Molecular Entity Review
1 products under this application
- ULTANE · SEVOFLURANE 100% · LIQUID, INHALATION · Prescription · TE AN
Clinical trials
Interventional ClinicalTrials.gov studies with "Sevoflurane" as an intervention, any sponsor and status, largest first.
Vanderbilt UniversityAcademic, hospital or other
NCT02625181 · 27,034 participants · Start Jul 2016 · Primary completion Nov 2, 2017
Drug: Propofol; Sevoflurane and 28 more · For: Postoperative Nausea and Vomiting
Sites: Nashville, Tennessee
Vanderbilt University Medical CenterAcademic, hospital or other
NCT02726620 · 22,435 participants · Start Jan 5, 2017 · Primary completion Dec 31, 2017
Drug: Propofol; Sevoflurane and 32 more · For: Hypotension
Sites: Nashville, Tennessee
- Long-term Outcome of General Anesthesia on DysgnosiaPivotal-lookingStatus unknown
Nanjing Medical UniversityAcademic, hospital or other
NCT01184638 · 10,000 participants (planned) · Start Aug 2010 · Primary completion Aug 2020
Drug: Sevoflurane; Propofol · For: Delirium,; Dementia,; Amnestic, and 1 more
Sites: Nanjing, China
- Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane AnesthesiaPivotal-lookingCompleted
Uppsala UniversityAcademic, hospital or other
NCT01975064 · 5,774 participants · Start Nov 2013 · Primary completion Aug 31, 2022
Drug: Propofol; Sevoflurane · For: Breast Neoplasms; Colonic Neoplasms; Rectal Neoplasms
Sites: Beijing, China; Shanghai, China; Xijing, China · 15 sites in all
- Volatile Anesthetics to Reduce Mortality in Cardiac SurgeryPivotal-lookingCompleted
Università Vita-Salute San RaffaeleAcademic, hospital or other
NCT02105610 · 5,400 participants · Start Apr 14, 2014 · Primary completion Oct 2017
Drug: desflurane, isoflurane, sevoflurane; total intravenous anesthetics · For: Aortocoronary Bypass; Cardiac Surgery; Coronary Artery Bypass Grafting
Sites: Bahrein, Bahrain; São Paulo, Brazil; Burgas, Bulgaria · 36 sites in all
- Anesthesia and Non-small Cell Lung Cancer RecurrencePivotal-lookingRecruiting
Samsung Medical CenterAcademic, hospital or other
NCT06330038 · 5,384 participants (planned) · Start Aug 5, 2024 · Primary completion Dec 31, 2028
Drug: Propofol; Inhaled anesthetics · For: Non-small Cell Lung Cancer; Surgery; Anesthesia
Sites: Seoul, South Korea
- Regional Anesthesia and Breast Cancer RecurrencePivotal-lookingCompleted
The Cleveland ClinicAcademic, hospital or other
NCT00418457 · 2,108 participants · Start Jan 2007 · Primary completion Feb 2018
Drug: General anesthesia and opioids; Regional analgesia and propofol · For: Breast Neoplasms
Sites: Cleveland, Ohio; Vienna, Austria; Beijing, China · 6 sites in all
- Anesthesia and Perioperative Neurocognitive Disorders in the Elderly Patients Undergoing Hip Fracture Surgery Platform Trial (ANDES Platform Trial)Pivotal-lookingRecruiting
Second Affiliated Hospital of Wenzhou Medical UniversityAcademic, hospital or other
NCT06452147 · 1,860 participants (planned) · Start Jun 19, 2024 · Primary completion Jul 30, 2028
Drug: Bupivacaine liposome; Regular local anesthetic and 1 more · For: Anesthesia; Hip Fractures; Dementia and 2 more
Sites: Dongyang, China; Hangzhou, China; Jinhua, China · 13 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- hypotension612
- anaesthetic complication neurological522
- drug interaction499
- cardiac arrest430
- bradycardia380
- hyperthermia malignant299
- drug ineffective298
- tachycardia279
- anaphylactic shock263
- serotonin syndrome252
- anaphylactic reaction237
- foetal exposure during pregnancy236
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 183 |
| 2005 | 143 |
| 2006 | 145 |
| 2007 | 190 |
| 2008 | 251 |
| 2009 | 281 |
| 2010 | 245 |
| 2011 | 371 |
| 2012 | 432 |
| 2013 | 417 |
| 2014 | 304 |
| 2015 | 237 |
| 2016 | 382 |
| 2017 | 328 |
| 2018 | 445 |
| 2019 | 348 |
| 2020 | 401 |
| 2021 | 497 |
| 2022 | 460 |
| 2023 | 524 |
| 2024 | 449 |
| 2025 | 684 |
| 2026 | 704 |
Recalls
1 FDA enforcement reports for this application.
Jan 22, 2018 · Class III · Terminated
Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Sevoflurane in electroconvulsive therapy: A systematic review and meta-analysis of randomised trials.
Aoki N, Suwa T, Kawashima H, et al. · J Psychiatr Res 2021 · Meta-Analysis, Research Support, Non-U.S. Gov't
- Renal safety of critical care sedation with sevoflurane: a systematic review and meta-analysis.
Taylor B, Scott TE, Shaw J, et al. · J Anesth 2023 · Meta-Analysis, Systematic Review
- Do Intraocular Pressure Measurements Under Anesthesia Reflect the Awake Condition?
Gofman N, Cohen B, Matot I, et al. · J Glaucoma 2017 · Randomized Controlled Trial
- Sevoflurane elimination kinetics in children.
Landais A, Saint-Maurice C, Hamza J, et al. · Paediatr Anaesth 1995 · Clinical Trial, Comparative Study
- A comparison of sevoflurane with halothane for paediatric day case surgery.
Walker SM, Haugen RD, Richards A · Anaesth Intensive Care 1997 · Clinical Trial, Clinical Trial, Phase III
- Short-term Outcomes in Infants after General Anesthesia with Low-dose Sevoflurane/Dexmedetomidine/Remifentanil versus Standard-dose Sevoflurane (the TREX Trial).
Saynhalath R, Disma N, Taverner FJ, et al. · Anesthesiology 2024 · Randomized Controlled Trial, Multicenter Study
Sponsor: AbbVie
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.